
Minerva Neurosciences webinar reported that roluperidone monotherapy improved primary negative symptoms and functioning in stable patients with schizophrenia who had a low relapse risk.
What major challenges do patients with tardive dyskinesia face in their daily lives? Take the quiz and learn more.
Potential adverse consequences of TD include which of the following:






